Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine

Overview of attention for article published in The Journal of Headache and Pain, May 2022

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,493 followers.

RT @EHF_Official: A recent real-world #study proved the effectiveness of #fremanezumab in difficult-to-treat (DTT) patients regardless of #…

A recent real-world #study proved the effectiveness of #fremanezumab in difficult-to-treat (DTT) patients regardless of #migraine type or the presence of factors contributing to DTT migraine. #headche #research #therapy Read more: https://t.co/PIL1nCKHdZ h

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.